Prot# EPO-CAN-303: A Double-Blind, Placebo-Controlled, Multicenter, Randomized, Phase-3 Study of Epoetin Alfa in the Treatment of Anemia in Cancer Subjects Not Currently Treated with Chemotherapy or Radiotherapy

Project: Research project

Project Details

StatusFinished
Effective start/end date9/7/04 → 11/9/05

Funding

  • Johnson & Johnson (EPO-CAN-303)